Position in TEVA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$602,400
-$958,100 QoQ
Shares Held
20,000
-60.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RBF Capital, LLC holds $2,535,600 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
|
180,000 | $1,933,200 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
20,000 | $602,400 |
All Filings in TEVA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $602,400 | 20,000 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,560,500 | 50,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,010,000 | 50,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $838,000 | 50,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $768,500 | 50,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,102,000 | 50,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,621,800 | 90,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,462,500 | 90,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,411,000 | 100,000 | Shares | Sole | 2024-05-15 | |
| 2022-09-30 | $564,900 | 70,000 | Shares | Sole | 2022-11-14 | |
| 2020-09-30 | $360,400 | 40,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||